Lenome 5mg Capsule Supplier USA | Pharmaceutical Exporter from India

Lenome 5mg Capsule: Premier Immunomodulatory Therapy for Hematological Oncology

Are you searching for a reliable Lenome 5 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of advanced oncology medications. We cater to major international markets, including the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, providing high-quality pharmaceutical solutions with professional B2B support.

Product Overview: What is Lenome 5mg?

Lenome 5 mg is an oral medication containing Lenalidomide, a potent Immunomodulatory Agent (IMiD). It is a cornerstone in the treatment of various plasma cell dyscrasias and hematological malignancies. As a high-value oncology export, Lenome 5mg is trusted by healthcare providers globally for its efficacy in managing complex blood cancers.

Primary Therapeutic Indications:

Lenome 5 mg is clinically indicated for:

• Multiple Myeloma (MM): Used in combination with dexamethasone for newly diagnosed patients or those who have received at least one prior therapy.

• Myelodysplastic Syndromes (MDS): Specifically for transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

• Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after prior therapies.

• Follicular Lymphoma (FL): In combination with rituximab for previously treated patients.

Mechanism of Action: How Lenome Works

Lenome (Lenalidomide) operates through a multi-faceted approach to combat malignant cells:

1. Direct Tumor Inhibition: It induces cell cycle arrest and apoptosis (programmed cell death) in hematopoietic tumor cells.

2. Immune System Modulation: It enhances T cell and Natural Killer (NK) cell-mediated immunity, significantly boosting the body's natural ability to destroy cancer cells.

3. Anti-Angiogenesis: It inhibits the growth of new blood vessels that tumors need to grow and spread.

4. Cytokine Regulation: It reduces the production of pro-inflammatory cytokines like TNF-$\alpha$, creating an unfavorable environment for tumor survival.

Dosage and Administration Guidelines: 

• Cycles: Often prescribed in 28-day cycles (e.g., daily for 21 days followed by a 7-day rest period).

• Administration: Capsules should be swallowed whole with water, at approximately the same time each day. Do not break, chew, or open the capsules.

• Monitoring: Patients must undergo regular blood counts (CBC) to monitor for bone marrow suppression.

• Safety: Due to its structural relationship to thalidomide, Lenome is subject to strict pregnancy prevention programs globally.

Common Side Effects:

Healthcare providers should monitor for:

• Neutropenia (low white blood cell count) and Thrombocytopenia.

• Fatigue and diarrhea.

• Increased risk of Venous Thromboembolism (blood clots).

• Skin rashes.

Why Source Lenome 5 mg from Ernest Oncology?

• Global Logistics Expertise: Direct shipping and customs handling for the USA, UK, UAE, Australia, and South Africa. 

• Quality Assurance: Authentic medications sourced from GMP compliant manufacturers in India.

• Bulk Availability: Consistent stock levels of 5 mg, 10 mg, 15 mg, and 25 mg strengths for hospital and clinical supply.

• B2B Competitive Pricing: Optimized rates for international pharmaceutical distributors and oncology centers.